T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.4 CNY -4.66% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Net Margin
Tianjin Ringpu Bio-Technology Co Ltd

17.6%
Current
19%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.6%
=
Net Income
424m
/
Revenue
2.4B

Net Margin Across Competitors

Country CN
Market Cap 8.6B CNY
Net Margin
18%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

Tianjin Ringpu Bio-Technology Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Pharmaceuticals

Tianjin Ringpu Bio-technology Co., Ltd. engages in the provision of animal health services. The company is headquartered in Tianjin, Tianjin and currently employs 2,701 full-time employees. The company went IPO on 2010-09-17. The firm operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Intrinsic Value
24.46 CNY
Undervaluation 25%
Intrinsic Value
Price
T

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.6%
=
Net Income
424m
/
Revenue
2.4B
What is the Net Margin of Tianjin Ringpu Bio-Technology Co Ltd?

Based on Tianjin Ringpu Bio-Technology Co Ltd's most recent financial statements, the company has Net Margin of 17.6%.